Page last updated: 2024-10-30

letrozole and Colorectal Neoplasms

letrozole has been researched along with Colorectal Neoplasms in 2 studies

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
"Postmenopausal women with early breast cancer (EBC) are already at risk for bone loss, osteoporosis and fracture as they age because of declining estrogen levels."2.46Women and bone health: maximizing the benefits of aromatase inhibitor therapy. ( Tang, SC, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, SC1
Paleja, M1
Gorthi, G1
Scott, H1
Johnson, T1

Reviews

1 review available for letrozole and Colorectal Neoplasms

ArticleYear
Women and bone health: maximizing the benefits of aromatase inhibitor therapy.
    Oncology, 2010, Volume: 79, Issue:1-2

    Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplast

2010

Other Studies

1 other study available for letrozole and Colorectal Neoplasms

ArticleYear
Rare case of ER positive colorectal stricture demonstrating improvement with letrozole.
    BMJ case reports, 2011, Dec-01, Volume: 2011

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Colorectal Neoplasms; Constriction, Pathologic; Female;

2011